EMD-94246

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameEMD-94246
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonists
TargetsEndothelin receptor type A
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A